 BOSTON and LOUISVILLE, Ky., Oct. 28, 2021 GLOBE NEWSWIRE -- Talaris Therapeutics, Inc. Nasdaq: TALS, a late-clinical stage cell therapy company, today announced upcoming data presentations at the American Society of Nephrology ASN Kidney Week 2021, taking place November 4-7, 2021. 